Scholarlink

<p>A novel ruthenium(II) compound, <i>cis</i>-[Ru(phen)<sub>2</sub>(4-bzpy)(Cl)](PF<sub>6</sub>) (complex I), where phen = 1,10-phenanthroline and 4-bzpy = 4-benzoylpyridine, was synthesized and fully characterized using electrochemical and spectroscopic methods, and its structure was determined by single-crystal X-ray diffraction. Density functional theory (DFT) and time-dependent DFT calculations were performed to shed light on the electronic structure and nature of the vibrational and electronic transitions. The photochemical behavior of complex I in aqueous solution showed that irradiation with blue light (453&#xa0;nm) promoted the release of the coordinated 4-bzpy ligand originating <i>cis</i>-[Ru(phen)<sub>2</sub>(H<sub>2</sub>O)(Cl)]<sup>+</sup> ion, as identified by NMR and electronic spectroscopy. Moreover, complex I exhibited a great ability to cleave DNA molecules upon blue light irradiation, which was associated with the production of reactive oxygen species (singlet oxygen and superoxide anion). In this study, we also investigated the antimicrobial activity of complex I along with a similar compound, <i>cis</i>-[Ru(bpy)<sub>2</sub>(4-bzpy)(Cl)](PF<sub>6</sub>) (complex II), their precursors [Ru(bpy)<sub>2</sub>Cl<sub>2</sub>] and [Ru(phen)<sub>2</sub>Cl<sub>2</sub>], and the free ligand 4-bzpy. These two ruthenium complexes I and II have a common auxiliary ligand 4-bzpy, but distinct chelating ligands (phenanthroline or 2,2′-bipyridine, bpy). Notably, both complexes showed promising antibacterial activity against Gram-positive bacterial strains of <i>Staphylococcus aureus</i> and <i>Staphylococcus epidermidis</i>. However, complex I showed a superior antibacterial effect compared with complex II, supporting the important role of the phen ligand, likely providing greater lipophilicity to this compound.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Novel phenanthroline-based ruthenium complex as a promising antimicrobial agent

  • 期刊论文

  • 发表日期：

    2025年8月20日

查看全文
  • Pedro L. N. Teixeira,
  • Ana C. S. Gondim,
  • Tercio F. Paulo,
  • Eduardo H. S. Sousa,
  • Luiz G. F. Lopes,
  • Alejandro P. Ayala,
  • Ellen A. Malveira,
  • Edson H. Teixeira,
  • Mayron A. Vasconcelos,
  • Alda K. M. Holanda

摘要

A novel ruthenium(II) compound, cis-[Ru(phen)2(4-bzpy)(Cl)](PF6) (complex I), where phen = 1,10-phenanthroline and 4-bzpy = 4-benzoylpyridine, was synthesized and fully characterized using electrochemical and spectroscopic methods, and its structure was determined by single-crystal X-ray diffraction. Density functional theory (DFT) and time-dependent DFT calculations were performed to shed light on the electronic structure and nature of the vibrational and electronic transitions. The photochemical behavior of complex I in aqueous solution showed that irradiation with blue light (453 nm) promoted the release of the coordinated 4-bzpy ligand originating cis-[Ru(phen)2(H2O)(Cl)]+ ion, as identified by NMR and electronic spectroscopy. Moreover, complex I exhibited a great ability to cleave DNA molecules upon blue light irradiation, which was associated with the production of reactive oxygen species (singlet oxygen and superoxide anion). In this study, we also investigated the antimicrobial activity of complex I along with a similar compound, cis-[Ru(bpy)2(4-bzpy)(Cl)](PF6) (complex II), their precursors [Ru(bpy)2Cl2] and [Ru(phen)2Cl2], and the free ligand 4-bzpy. These two ruthenium complexes I and II have a common auxiliary ligand 4-bzpy, but distinct chelating ligands (phenanthroline or 2,2′-bipyridine, bpy). Notably, both complexes showed promising antibacterial activity against Gram-positive bacterial strains of Staphylococcus aureus and Staphylococcus epidermidis. However, complex I showed a superior antibacterial effect compared with complex II, supporting the important role of the phen ligand, likely providing greater lipophilicity to this compound.

Graphical Abstract